|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsored by: |
Sheba Medical Center |
| Information provided by: | Sheba Medical Center |
| ClinicalTrials.gov Identifier: | NCT00416143 |
Purpose
sudden sensorineural hearing loss:
| Condition | Intervention | Phase |
|
Sudden Loss of Hearing |
Procedure: bed rest Drug: prednisone - oral corticosteroid 1mg/kg/D for 1 week |
Phase II Phase III |
| Genetics Home Reference related topics: | nonsyndromic deafness |
| MedlinePlus related topics: | Hearing Disorders and Deafness |
| ChemIDplus related topics: | Prednisone Corticosteroids |
| Study Type: | Interventional |
| Study Design: | Treatment, Non-Randomized, Open Label, Placebo Control, Parallel Assignment, Safety/Efficacy Study |
| Official Title: | Bed Rest for Idiopathic Sudden Sensorineural Hearing Loss |
Eligibility
| Ages Eligible for Study: | 16 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| Contact: Eldar Carmel, MD | 972-3-5302442 | eldarca@sheba.health.gov.il |
| Israel | |||||
| Sheba Medical Center | Recruiting | ||||
| TEL HASHOMER, Israel | |||||
| Contact: Eldar Carmel, MD 972-3-5302442 eldarca@sheba.health.gov.il | |||||
| Principal Investigator: Eldar Carmel, MD | |||||
| Sheba Medical Center |
| Principal Investigator: | Eldar Carmel, MD | Sheba Medical Center |
More Information
| Study ID Numbers: | SHEBA-06-4065-EC-CTIL |
| First Received: | December 24, 2006 |
| Last Updated: | December 24, 2006 |
| ClinicalTrials.gov Identifier: | NCT00416143 |
| Health Authority: | Israel: Israeli Health Ministry Pharmaceutical Administration |
|
|
|
|